Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Impact of Maternal-Fetal Outcomes and Breastfeeding on Cardiac Reverse Remodeling
Session:
SESSÃO DE POSTERS 46 - EPIDEMIOLOGIA PORTUGUESA NO FOCO
Speaker:
Rui Martins Alves
Congress:
CPC 2025
Topic:
K. Cardiovascular Disease In Special Populations
Theme:
30. Cardiovascular Disease in Special Populations
Subtheme:
30.7 Pregnancy and Cardiovascular Disease
Session Type:
Cartazes
FP Number:
---
Authors:
Rui Martins Alves; Ana Filipa Ferreira; Ana Barros; Juliana Morais; Débora Veiga; Maria João Azevedo; Carla Sousa; Ana Paula Machado; Adelino Leite-Moreira; Carla Ramalho; Inês Falcão-Pires; António S. Barros
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Introduction</strong></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">: Pregnancy induces cardiac remodeling characterized by left ventricular (LV) hypertrophy and dilation, which is expected to return to its pre-pregnancy structure after delivery, cardiac reverse remodeling (RR). However, the impact of maternal-fetal outcomes and breastfeeding on cardiac RR is not yet well established.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Aim</strong></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">: To investigate the impact of maternal-fetal outcomes [cardiovascular risk (CVR) factors (chronic arterial hypertension, obesity, and type 2 diabetes mellitus), pregnancy complications (preeclampsia, gestational diabetes and gestational hypertension), duration, parity, newborn sex, delivery type], and exclusive breastfeeding on LV mass (LVM) regression induced by pregnancy.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Methods</strong></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">: This prospective cohort study included volunteer pregnant women from two tertiary centers between 2019 and 2024. Participants underwent transthoracic echocardiography during the 3</span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><sup>rd</sup></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"> trimester [30–35 weeks, peak of cardiac remodeling], as well as at 1/6/12 months postpartum [cardiac RR]. Generalized linear mixed-effects models were used to evaluate the extent of the RR and its predictors.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Results: </strong></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">A total of 169 participants were included, with a median age of 34[31;37] years, 36% of whom had at least one CVR factor. Pregnancy complications occurred in 30% of the women. The median time of gestation was 39[38; 40] weeks. C-section delivery was performed in 37% of the participants, and 53% of the newborns were male. Most of the participants were primiparous (53%). Exclusive breastfeeding for up to 4.5 months was documented in 39% of women. Significant regression of LVM (34[29;39]g/m</span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><sup>2.7</sup></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"> to 31[26; 36]g/m</span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><sup>2.7</sup></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">, p<0.001), volume (25[22;28]mL/m</span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><sup>2.7</sup></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"> to 23[20;26]mL/m</span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><sup>2.7</sup></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">, p<0.001), and relative wall thickness (0.36[0.32;0.40] to 0.33[0.30;0.37], p<0.001) were found as soon as 1 month postpartum.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">In the multivariable analysis, the presence of maternal CVR factors (7.39[5.47;9.31], p<0.001) and the number of live births before this pregnancy (1.41[0.02;2.80], p=0.048) were independent predictors of postpartum LVM regression. Pregnancy complications, newborn sex, c-section, pregnancy duration, maternal age, and exclusive breastfeeding for up to 4.5 months showed a non-significant impact on postpartum LVM regression.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Conclusion</strong></span></span></span><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">: Substantial LVM regression was observed as early as 1 month postpartum. The presence of maternal CVR factors and an increased number of previous live births significantly influenced cardiac RR, diminishing the regression of postpartum LVM.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site